Time-to-Event Modeling for Survival Prediction of Osimertinib As the First- and Second-Line Therapy
Journal of Clinical Medicine（2025）
Key words
non-small cell lung cancer (NSCLC),time-to-event modeling,Osimertinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined